Clinical study on the multi-center randomized controlled optimization scheme of Shugan Tiaoshen integrated acupuncture in the treatment of moderate depressive disorder

Phase 1

Recruiting

• Conditions: Depression

• Registration Number: ITMCTR2100004326
• Lead Sponsor: Guangdong Provincial Hospital of Traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. In line with the diagnostic criteria of Chinese and Western medicine;
2. Age 18 ~ 65 years old, junior high school (including) or above;
3. The 17 Hamilton Depression Scale (HAMD-17) scores were > 17 and <= 24;
4. Signed the informed consent and volunteered to participate in the study.
Only those who meet the above four criteria can be included in the study.

Exclusion Criteria

1. People with suicidal tendencies;
2. Previous diagnosis of mental disorders, schizophrenia, bipolar disorder, substance abuse (such as: alcohol dependence) or other mental disorders;
3. Epileptic seizure history or strong positive family history of epilepsy, brain organic disease and severe physical disease;
4. Taking antidepressant drugs within 6 weeks (including 6 weeks);
5. Pregnancy, pregnancy preparation or lactation;
6. Patients with skin lesions or skin diseases, severe diabetes mellitus, tumors, insufficiency of important organs or serious internal diseases such as liver, kidney, cardiovascular, endocrine, respiratory system and hematopoietic system;
Those who meet any of the above criteria will be excluded from the study.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
HAMD-17;

Secondary Outcome Measures

Name	Time	Method
HAMA;Body motion records data;Pittsburgh sleep quali-ty index;